Detection of lactate with a Hadamard slice selected, selective multiple quantum coherence, chemical shift imaging sequence (HDMD-SelMQC-CSI) on a clinical MRI scanner: Application to tumors and muscle ischemia

Magnetic Resonance in Medicine

Volumn 62, Issue 6, 2009, Pages 1404-1413

  Mellon, Eric A ^a   Lee, Seung Cheol ^a   Pickup, Stephen ^a   Kim, Sungheon ^b   Goldstein, Steven C ^c   Floyd, Thomas F ^c   Poptani, Harish ^a   Delikatny, E James ^a   Reddy, Ravinder ^a   Glickson, Jerry D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Blood flow occlusion; Hadamard encoding; Lactate imaging; Magnetic resonance spectroscopy; Non Hodgkin's lymphoma

Indexed keywords

CHEMICAL DETECTION; CHEMICAL SHIFT; ENCODING (SYMBOLS); MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; METABOLITES; MUSCLE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONCOLOGY; SCANNING; SIGNAL ENCODING; TUMORS;

BLOOD FLOW OCCLUSION; CHEMICAL SHIFT IMAGING; CLINICAL FEASIBILITY; CLINICAL SCANNERS; FLOW CONSTRICTION; HADAMARD; MULTIPLE-QUANTUM COHERENCES; NON-HODGKIN'S LYMPHOMA;

QUANTUM THEORY;

LACTIC ACID;

ADULT; AMPLITUDE MODULATION; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; FEASIBILITY STUDY; FEMALE; HUMAN; IN VIVO STUDY; MUSCLE ISCHEMIA; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE SCANNER; PHANTOM; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTUM MECHANICS; THREE DIMENSIONAL IMAGING; TOURNIQUET; TUMOR;

EID: 73149106608     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22141     Document Type: Article

References (41)

1. Czernin J, Phelps ME. Positron emission tomography scanning: current and future applications. Annu Rev Med 2002;53:89-112.
2. Lee SC, Huang MQ, Nelson DS, Pickup S, Wehrli S, Adegbola O, Poptani H, Delikatny EJ, Glickson JD. In vivo MRS markers of response to CHOP chemotherapy in the WSU-DLCL2 human diffuse large B-cell lymphoma xenograft. NMR Biomed 2008;21:723-733.
3. Poptani H, Bansal N, Graham RA, Mancuso A, Nelson DS, Glickson JD. Detecting early response to cyclophosphamide treatment of RIF-1 tumors using selective multiple quantum spectroscopy (SelMQC) and dynamic contrast enhanced imaging. NMR Biomed 2003;16:102-111.
4. Lee SC, Delikatny EJ, Poptani H, Pickup S, Glickson JD. In vivo (1)H MRS of WSU-DLCL2 human non-Hodgkin's lymphoma xenografts: response to rituximab and rituximab plus CHOP. NMR Biomed 2009;22: 259-265.
5. Bhujwalla ZM, Glickson JD. Detection of tumor response to radiation therapy by in vivo proton MR spectroscopy. Int J Radiat Oncol Biol Phys 1996;36:635-639.
6. Liu YJ, Chen CY, Chung HW, Huang IJ, Lee CS, Chin SC, Liou M. Neuronal damage after ischemic injury in the middle cerebral arterial territory: deep watershed versus territorial infarction at MR perfusion and spectroscopic imaging. Radiology 2003;229:366-374.
7. Moller HE, Kurlemann G, Putzler M, Wiedermann D, Hilbich T, Fiedler B. Magnetic resonance spectroscopy in patients with MELAS. J Neurol Sci 2005;229-230:131-139.
8. Harris K, Walker PM, Mickle DA, Harding R, Gatley R, Wilson GJ, Kuzon B, McKee N, Romaschin AD. Metabolic response of skeletal muscle to ischemia. Am J Physiol 1986;250(2 pt 2):H213-220.
9. Robergs RA, Ghiasvand F, Parker D. Biochemistry of exercise-induced metabolic acidosis. Am J Physiol Regul Integr Comp Physiol 2004;287: R502-516.
10. Keller U, Oberhansli R, Huber P, Widmer LK, Aue WP, Hassink RI, Muller S, Seelig J. Phosphocreatine content and intracellular pH of calf muscle measured by phosphorus NMR spectroscopy in occlusive arterial disease of the legs. Eur J Clin Invest 1985;15:382-388.
11. Greiner A, Esterhammer R, Messner H, Biebl M, Muhlthaler H, Fraedrich G, Jaschke WR, Schocke MF. High-energy phosphate metabolism during incremental calf exercise in patients with unilaterally symptomatic peripheral arterial disease measured by phosphor 31 magnetic resonance spectroscopy. J Vasc Surg 2006;43:978-986.
12. Williams DM, Fencil L, Chenevert TL. Peripheral arterial occlusive disease: P-31 MR spectroscopy of calf muscle. Radiology 1990;175: 381-385.
13. Schunk K, Romaneehsen B, Mildenberger P, Kersjes W, Schadmand-Fischer S, Thelen M. Dynamic phosphorus-31 magnetic resonance spectroscopy in arterial occlusive disease. Correlation with clinical and angiographic findings and comparison with healthy volunteers. Invest Radiol 1997;32:651-659.
14. Li X, Vigneron DB, Cha S, Graves EE, Crawford F, Chang SM, Nelson SJ. Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo. AJNR Am J Neuroradiol 2005;26:760-769.
15. Allen PS, Thompson RB, Wilman AH. Metabolite-specific NMR spectroscopy in vivo. NMR Biomed 1997;10:435-444.
16. van Dijk JE, Mehlkopf AF, Bovee WM. Comparison of double and zero quantum NMR editing techniques for in vivo use. NMR Biomed 1992; 5:75-86.
17. He Q, Shungu DC, van Zijl PC, Bhujwalla ZM, Glickson JD. Single-scan in vivo lactate editing with complete lipid and water suppression by selective multiple-quantum-coherence transfer (Sel-MQC) with application to tumors. J Magn Reson B 1995;106:203-211.
18. Sotak CH, Freeman DM. A method for volume-localized lactate editing using zero-quantum coherence created in a stimulated-echo pulse sequence. J Magn Reson 1988;77:382-388.
19. Jouvensal L, Carlier PG, Bloch G. Practical implementation of single-voxel double-quantum editing on a whole-body NMR spectrometer: localized monitoring of lactate in the human leg during and after exercise. Magn Reson Med 1996;36:487-490.
20. Lei H, Dunn J. The effects of slice-selective excitation/refocusing in localized spectral editing with gradient-selected double-quantum coherence transfer. J Magn Reson 2001;150:17-25.
21. He Q, Shkarin P, Hooley RJ, Lannin DR, Weinreb JC, Bossuyt VI. In vivo MR spectroscopic imaging of polyunsaturated fatty acids (PUFA) in healthy and cancerous breast tissues by selective multiple-quantum coherence transfer (Sel-MQC): a preliminary study. Magn Reson Med 2007;58:1079-1085.
22. Souza SP, Szumowski J, Dumoulin CL, Plewes DP, Glover G. SIMA: simultaneous multislice acquisition of MR images by Hadamard-encoded excitation. J Comput Assist Tomogr 1988;12:1026-1030.
23. 1H spectroscopy of human brain by using a hybrid of 1D-Hadamard with 2D-chemical shift imaging. Magn Reson Med 1997;37:644-650.
24. Pickup S, Lee SC, Mancuso A, Glickson JD. Lactate imaging with Hadamard-encoded slice-selective multiple quantum coherence chemical-shift imaging. Magn Reson Med 2008;60:299-305.
25. Roemer PB, Edelstein WA, Hayes CE, Souza SP, Mueller OM. The NMR phased array. Magn Reson Med 1990;16:192-225.
26. Callaghan PT. Principles of nuclear magnetic resonance microscopy. Oxford: Clarendon; 1994. p. 516.
27. Goelman G, Leigh JS. Multiband adiabatic inversion pulses. J Magn Reson A 1993;101:136-146.
28. Ogg RJ, Kingsley PB, Taylor JS. WET, a T1-and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy. J Magn Reson B 1994;104:1-10.
29. Wu W, Wang J, Detre J, Wehrli F, Mohler E 3rd, Ratcliffe S, Floyd T. Hyperemic flow heterogeneity within the calf, foot, and forearm measured with continuous arterial spin labeling MRI. Am J Physiol Heart Circ Physiol 2008;294:H2129.
30. Wu W, Wang J, Detre J, Ratcliffe S, Floyd T. Transit delay and flow quantification in muscle with continuous arterial spin labeling perfusion-MRI. J Magn Reson Imaging 2008;28:445-452.
31. Mellon EA, Pickup S, Isaac G, Lee SC, Delikatny EJ, Reddy R, Glickson JD. Imaging of physiologic lactate concentrations by SelMQC spectroscopy with Hadamard slice selection on a clinical scanner. Proceedings of the 16th Scientific Meeting, International Society for Magnetic Resonance in Medicine, Toronto, 2008. p 1577.
32. 1H-NMR detectable fatty acyl chain unsaturation in excised leiomyosarcoma correlate with grade and mitotic activity. J Clin Invest 1996;98:244-250.
33. Ordidge RJ, Connelly A, Lohman JAB. Image-selected in vivo spectroscopy (ISIS). A new technique for spatially selective NMR spectroscopy. J Magn Reson 1986;66:283-294.
34. Arias-Mendoza F, Smith MR, Brown TR. Predicting treatment response in non-Hodgkin's lymphoma from the pretreatment tumor content of phosphoethanolamine plus phosphocholine. Acad Radiol 2004;11: 368-376.
35. Arias-Mendoza F, Payne GS, Zakian K, Stubbs M, Cruz-Lobo JG, Schwarz AJ, Dave A, Howe F, Maisey NR, Cunningham D, Poptani H, Smith MR, O'Connor OA, Pettengell R, Leach MO, Koutcher JA, Griffiths JR, Heerschap AH, Glickson JD. Treatment response predictor using 31P MRS for CHOP and R-CHOP therapy in diffuse large B-cell lymphoma. Proceedings of the 16th Scientific Meeting, International Society for Magnetic Resonance in Medicine, Toronto, 2008. p 768.
36. Kumar R, Maillard I, Schuster SJ, Alavi A. Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas. Radiol Clin North Am 2004;42:1083-1100.
37. Quistorff B, Johansen L, Sahlin K. Absence of phosphocreatine resynthesis in human calf muscle during ischaemic recovery. Biochem J 1993;291(pt 3):681-686.
38. 31P MRS studies of exercising human muscle at high temporal resolution. Magn Reson Med 1999;41:1145-1151.
39. Pipinos II, Shepard AD, Anagnostopoulos PV, Katsamouris A, Boska MD. Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle. J Vasc Surg 2000;31:944-952.
40. 1H-NMR spectroscopy. J Exp Biol 2003; 206(pt 17):3043-3052.
41. van der Grond J, Braun KPJ. Incorrect echo times yield a 10% reduction in the lactate intensity and a 9% reduction in the T2 of lactate. Proceedings of the 8th Scientific Meeting, International Society for Magnetic Resonance in Medicine, Denver, 2000. p 1952.